Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;84(1):34-50.
doi: 10.3348/jksr.2022.0136. Epub 2023 Jan 30.

[Lung Imaging Reporting and Data System (Lung-RADS) in Radiology: Strengths, Weaknesses and Improvement]

[Article in Korean]
Review

[Lung Imaging Reporting and Data System (Lung-RADS) in Radiology: Strengths, Weaknesses and Improvement]

[Article in Korean]
Gong Yong Jin. J Korean Soc Radiol. 2023 Jan.

Abstract

In 2019, the American College of Radiology announced Lung CT Screening Reporting & Data System (Lung-RADS) 1.1 to reduce lung cancer false positivity compared to that of Lung-RADS 1.0 for effective national lung cancer screening, and in December 2022, announced the new Lung-RADS 1.1, Lung-RADS® 2022 improvement. The Lung-RADS® 2022 measures the nodule size to the first decimal place compared to that of the Lung-RADS 1.0, to category 2 until the juxtapleural nodule size is < 10 mm, increases the size criterion of the ground glass nodule to 30 mm in category 2, and changes categories 4B and 4X to extremely suspicious. The category was divided according to the airway nodules location and shape or wall thickness of atypical pulmonary cysts. Herein, to help radiologists understand the Lung-RADS® 2022, this review will describe its advantages, disadvantages, and future improvements.

미국방사선의학회는 효과적인 국가 폐암 검진 시행을 위해 2019년도에 Lung CT Screening Reporting & Data System (이하 Lung-RADS) 1.0보다 폐암의 위양성을 줄이기 위해 개편된 Lung-RADS 1.1을 발표하였고, 2022년 12월에 새로운 Lung-RADS 1.1 개선안 Lung-RADS® 2022를 발표하였다. Lung-RADS ® 2022은 Lung-RADS 1.0과 비교했을 때 결절의 크기는 소수점 첫째 자리까지 측정하고, 늑막근처 결절의 크기가 10 mm 미만인 경우까지 범주 2로 하며, 범주 2에서 간유리 결절의 크기 기준을 30 mm로 높이고, 범주 4B와 4X는 매우 의심으로 변경하며, 기도 결절의 위치와 비정형 폐 낭종의 형태와 벽 두께에 따라 범위를 나누었다. 이에 영상의학과 의사들의 개선된 Lung-RADS® 2022에 대한 이해를 돕고자, 이 종설에서는 Lung-RADS® 2022의 장점, 단점, 그리고 향후 개선점에 대해서 기술하고자 한다.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. A 68-year-old male with a 30-pack-year smoking history with perifissural lymph node. There is a 7 mm triangular solid nodule (arrow) near the right major fissure on low-dose chest CT. It is category 3 in Lung RADS 1.0, but downgraded to category 2 in Lung RADS 1.1. and Lung-RADS® 2022.
Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 2
Fig. 2. A 57-year-old male with a 32-pack-year smoking history with perifissural lymph node.
A. There is a 20 mm lobular, ellipsoidal solid nodule (arrow) near the left major fissure on low-dose chest CT. In Lung RADS 1.1, it is considered category 4A. B. After one year, a follow-up low-dose chest CT shows no change in this perifissural lymph node (arrow) near the left major fissure. It is category 2 in Lung RADS 1.1. and Lung-RADS® 2022 and assigned to follow-up low-dose chest CT. Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 3
Fig. 3. A 60-year-old male with a 30-pack-year smoking history classified as category 4A in Lung RADS 1.1. and Lung-RADS® 2022.
A, B. If measured two-dimensionally, the nodule of the right lower lobe (A, arrow) is 8.2 mm, and the addition of the volumetric measurement (B) is 283.7 mm3 (arrow), all of which are category 4A. Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 4
Fig. 4. A 62-year-old male with a 30-pack-year smoking history with inflammatory nodule at follow-up CT.
A. There is a 9 mm sized cavitary nodule with spiculated margin (arrow) in right upper lobe. In Lung RADS 1.1 and Lung-RADS® 2022, it is considered as category 4X and 4A, respectively. B. After one month, on non-enhanced chest CT, the nodule size in the right upper lobe (arrow) reduced from 9 mm to 7 mm, and the nodule border changed from spiculated margin to irregular margin. C. No FDG uptake was noted on the nodule in the right upper lobe on 18F-FDG PET/CT. Video-assisted thoracic surgery was performed on the right upper lobe nodule, and the pathologic result was high grade glandular hyperplasia. FDG = fluorodeoxyglucose, Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 5
Fig. 5. A 71-year-old male with a 40-pack-year smoking history diagnosed with lung cancer within a year.
A. In low-dose chest CT, the subcarnial lymph node (arrow) had a short diameter of 6 mm; therefore, it was category 1. B. After 10 months, a follow-up chest CT with enhancement was performed for chronic cough, and the subcarinal lymph node (arrow) increased to 3 cm and was diagnosed with metastatic neuroendocrine carcinoma.
Fig. 6
Fig. 6. A 62-year-old male with a 42-pack-year smoking history classified as category 3 in Lung RADS 1.1 and Lung-RADS® 2022.
A. If measured two-dimensionally, there is a solid nodule with an irregular margin of 7.1 mm in right lower lobe. In Lung RADS 1.1 and Lung-RADS® 2022, it is categorized as Lung-RADS 3. B. If measured three-dimensionally, the same solid nodule is measured at 8.7 mm. In Lung RADS 1.1 and Lung-RADS® 2022, it is considered as category 4A. Consequently, the Lung-RADS for this nodule and false positive increased. Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 7
Fig. 7. Verification of variation in three-dimensional measurement of nodule in Lung-RADS 1.1 and Lung-RADS® 2022 using two different softwares.
A. The left upper lobe nodule on low-dose chest CT is 5.5 mm in diameter and 90 mm3 in volume if measured using software, which is category 2. B. If the same left upper lobe nodule is measured using another software, it is 5.6 mm in diameter and 91.8 mm3 in volume, which is category 2. In monitoring the same nodule measurement using two different softwares, there is a slight difference in the diameter and volume, but the category is the same. Lung-RADS = Lung CT Screening Reporting & Data System A B
Fig. 8
Fig. 8. A 72-year-old male with a 40-pack-year smoking history with atypical pulmonary cyst.
A. In the initial low-dose chest CT, 6 mm sized nodules and thin-walled cyst with 2 mm sized mural nodule (arrow) are present in the right upper lobe. Lung-RADS 1.1 does not provide a criterion on methods to measure the size of the cyst nodule, but the overall size of the nodule, including cyst, is 6 mm, which can be considered category 2. However, in Lung-RADS® 2022, this atypical pulmonary cyst can be considered category 3. B. After one year, if a follow-up examination was performed with low-dose chest CT, the cystic nodule in right upper lobe increased to 12.2 mm, and the thin walled cyst changed to the thickened irregular walled cavity with inner nodules (arrow). In Lung-RADS 1.1, it is considered as category 4X. However, the growing atypical pulmonary cyst can be considered as category 4B in Lung-RADS® 2022. Lung-RADS = Lung CT Screening Reporting & Data System
Fig. 9
Fig. 9. A 62-year-old male with a 30-pack-year smoking history and a subpleural nodule.
A. In the initial low-dose chest CT, there is a 6 mm round nodule (arrow) in the right lower lobe. In Lung-RADS 1.1, it is considered as category 3. However, the solid nodule can be considered as category 2 in Lung-RADS® 2022. B. After two years, the size of the right lower lobe nodule (arrow) reduced to 5 mm in follow-up low-dose chest CT, and its shape changed from round to circular. Lung-RADS = Lung CT Screening Reporting & Data System

References

    1. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022;54:330–344. - PMC - PubMed
    1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. - PMC - PubMed
    1. Lee J, Kim Y, Kim HY, Goo JM, Lim J, Lee CT, et al. Feasibility of implementing a national lung cancer screening program: interim results from the Korean Lung Cancer Screening Project (K-LUCAS) Transl Lung Cancer Res. 2021;10:723–736. - PMC - PubMed
    1. Lee J, Lim J, Kim Y, Kim HY, Goo JM, Lee CT, et al. Development of protocol for Korean Lung Cancer Screening Project (K-LUCAS) to evaluate effectiveness and feasibility to implement national cancer screening program. Cancer Res Treat. 2019;51:1285–1294. - PMC - PubMed
    1. Kastner J, Hossain R, Jeudy J, Dako F, Mehta V, Dalal S, et al. Lung-RADS version 1.0 versus lung-RADS version 1.1: comparison of categories using nodules from the national lung screening trial. Radiology. 2021;300:199–206. - PubMed